Eating Fish, Exercise Lower Risk for Colon Cancer Recurrence

Share this content:

the Cancer Therapy Advisor take:

One study presented at the 2014 ASCO Annual Meeting suggests that eating more fish and exercising can lower the risk for disease recurrence in patients with colon cancer. Researchers surveyed 1,515 patients with colon cancer in several different countries, 188 of whom had recurrent colon cancer. Results showed that those who ate less than two servings of fish per week were twice as likely to experience disease recurrence, as compared with those who ate more than two servings per week. Similarly, patients who exercised for less than 60 minutes per week were more than twice as likely to experience disease recurrence, as compared with those who exercise more, according to the study data. These findings imply the importance of diet, exercise, and lifestyle factors in cancer.

Fish, Exercise Lowers Risk for Colon Cancer Recurrence
Eating Fish, Exercise Lower Risk for Colon Cancer Recurrence
Eating fish and exercising are linked to a lower risk of cancer reccurrence in colon cancer patients, a new study suggests. In the new study, the researchers surveyed 1,515 colon cancer patients in Poland, Vietnam, Western Europe and the United States. Among these patients, 188 had recurrent colon cancer, meaning that their cancer had returned after treatment.
READ FULL ARTICLE From Yahoo News

Related Resources

Related Slideshows

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs